4.4 Article

Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF-γ in peripheral blood

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

LAG3 (CD223) as a cancer immunotherapy target

Lawrence P. Andrews et al.

IMMUNOLOGICAL REVIEWS (2017)

Article Medicine, Research & Experimental

Lymphocyte activation gene 3 and coronary artery disease

Diana Golden et al.

JCI INSIGHT (2016)

Article Pathology

LAG3 Expression in Active Mycobacterium tuberculosis Infections

Bonnie L. Phillips et al.

AMERICAN JOURNAL OF PATHOLOGY (2015)

Review Gastroenterology & Hepatology

Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer

Keunwook Lee et al.

GUT AND LIVER (2014)

Review Immunology

Targeting CD8+ T-cell tolerance for cancer immunotherapy

Stephanie R. Jackson et al.

IMMUNOTHERAPY (2014)

Article Gastroenterology & Hepatology

Gastric Cancer Epidemiology and Risk Factors

Catherine de Martel et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2013)

Article Rheumatology

Roles of LAG3 and EGR2 in regulatory T cells

Tomohisa Okamura et al.

ANNALS OF THE RHEUMATIC DISEASES (2012)

Article Hematology

Functional heterogeneity of human effector CD8+ T cells

Hiroshi Takata et al.

Article Biochemical Research Methods

ANALYSIS OF CD8+CD28- T-SUPPRESSOR CELLS IN GASTRIC CANCER PATIENTS

Yu Shen et al.

JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2012)

Review Pharmacology & Pharmacy

The CD4-like molecule LAG-3, biology and therapeutic applications

Sophie Sierro et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2011)

Article Oncology

Retrospective analysis of prognostic outcome of gastric cancer in young patients

Rieko Nakamura et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)